Annotated abstract

Correction: ‘Cost–utility analysis of MR imagingguided transurethral ultrasound ablation for the treatment of low- to intermediaterisk localised prostate cancer’

bmjpo · 2025-09-23 · canonical JSON source

2 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

Muhler P, AkuamoaBoateng D, Rosenbrock J, et al. Cost–utility analysis of MR imaging-guided transurethral ultrasound ablation for the treatment of low- to intermediate-risk localised prostate cancer. BMJ Open 2025;15:e088495. doi:10.1136/ bmjopen-2024–0 88 495